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Background: The Lung Injury Score (LIS) remains a commonly utilized measure of lung injury severity though the
additive value of LIS to predict ARDS outcomes over the recent Berlin definition of ARDS, which incorporates
severity, is not known.
Methods: We tested the association of LIS (in which scores range from 0 to 4, with higher scores indicating more
severe lung injury) and its four components calculated on the day of ARDS diagnosis with ARDS morbidity and
mortality in a large, multi-ICU cohort of patients with Berlin-defined ARDS. Receiver Operator Characteristic (ROC)
curves were generated to compare the predictive validity of LIS for mortality to Berlin stages of severity (mild,
moderate and severe).
Results: In 550 ARDS patients, a one-point increase in LIS was associated with 58% increased odds of in-hospital
death (95% CI 14 to 219%, P = 0.006), a 7% reduction in ventilator-free days (95% CI 2 to 13%, P = 0.01), and, among
patients surviving hospitalization, a 25% increase in days of mechanical ventilation (95% CI 9 to 43%, P = 0.001) and
a 16% increase (95% CI 2 to 31%, P = 0.02) in the number of ICU days. However, the mean LIS was only 0.2 points
higher (95% CI 0.1 to 0.3) among those who died compared to those who lived. Berlin stages of severity were
highly correlated with LIS (Spearman’s rho 0.72, P < 0.0001) and were also significantly associated with ARDS
mortality and similar morbidity measures. The predictive validity of LIS for mortality was similar to Berlin stages of
severity with an area under the curve of 0.58 compared to 0.60, respectively (P-value 0.49).
Conclusions: In a large, multi-ICU cohort of patients with ARDS, both LIS and the Berlin definition severity stages
were associated with increased in-hospital morbidity and mortality. However, predictive validity of both scores was
marginal, and there was no additive value of LIS over Berlin. Although neither LIS nor the Berlin definition were
designed to prognosticate outcomes, these findings suggest that the role of LIS in characterizing lung injury
severity in the era of the Berlin definition ARDS may be limited.
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Mortality in the acute respiratory distress syndrome
(ARDS) has declined significantly in the last decade as a re-
sult of improved supportive care, treatments for sepsis and
multi-organ failure, and the advent of low tidal volume ven-
tilation [1,2]. Accurate clinical measures of severity of
ARDS and mortality prediction are necessary to select* Correspondence: kkangelaris@medicine.ucsf.edu
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in any medium, provided the original work is pappropriate patients for clinical trials to detect the benefi-
cial effect of novel therapies [3-6]. Although not designed
to prognosticate outcomes, the recent Berlin definition for
ARDS was created, in part, to address the need for a con-
sistent measure of severity of ARDS that corresponded with
clinical outcomes [7]. Generated using an experimental
method combined with a consensus process to define
ARDS severity, the Berlin group considered the degree of
hypoxemia (PaO2/FiO2), in combination with ancillary
variables for severe ARDS including radiographic severity,
respiratory system compliance, positive end-expiratoryis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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to define lung injury severity. After testing these variables
in over 4,000 patients from multiple centers, they found
that only hypoxemia contributed to the predictive validity
of the definition. These findings raise the question of the
utility of these ancillary variables in describing severity of
lung injury.
The Lung Injury Score (LIS), proposed in 1988 by
Murray and colleagues, [8] has been a commonly uti-
lized measure of acute lung injury (ALI) severity in clin-
ical studies. Derived empirically by expert consensus, the
score is composed of four components: 1) chest radio-
graph; 2) hypoxemia score; 3) PEEP; and 4) static com-
pliance of respiratory system. The LIS preceded the first
consensus definition of ALI/ARDS (American-European
Consensus Committee (AECC) definition for ALI/
ARDS) in 1994, [9] and was designed to measure the
pathophysiological features of ARDS; however, it has not
been validated as an accurate measure of lung injury se-
verity and its use is not specific to ARDS [10]. Nonethe-
less, LIS has become a standard measure of ARDS
severity that remains widely used. In this capacity, LIS
has been presented as a measure of baseline lung injury
severity in ARDS clinical studies. In addition, LIS ≥ 3 has
been commonly used to identify severe ARDS for con-
sideration of possible rescue therapies, [11-13] and
changes in LIS over time have been used as a primary
physiologic endpoint to study the efficacy of interven-
tions [12,14]. The original manuscript [8], cited in over
1,400 scholarly articles, has accumulated over 67 new ci-
tations since 2012, many of which were published fol-
lowing the announcement of the Berlin definition of
ARDS [15].
Although LIS is frequently employed as a measure of the
severity of lung injury, its validity in predicting acute lung
injury-related outcomes has not been rigorously studied in
the era of lung-protective ventilation. Furthermore, the util-
ity of LIS in the context of the recently described Berlin
definition of ARDS, [7] which subdivides ARDS into three
levels of severity of hypoxemia, is not known. Thus, it is
important to determine whether LIS remains a useful
measure of lung injury severity in the broad spectrum of
patients treated for ARDS in modern clinical practice. This
study was designed to compare the association between LIS
and Berlin severity stages and in-hospital mortality and
morbidity in a large, prospective, multi-ICU cohort of pa-
tients meeting the Berlin definition of ARDS.
Methods
Subjects
We analyzed data drawn from a multi-ICU, prospective co-
hort study, entitled the Validation of biomarkers in Acute
Lung Injury Diagnosis (VALID) study, the primary purpose
of which is to identify biomarkers of diagnosis andprognosis in ARDS. Patients at Vanderbilt University Med-
ical Center (VUMC) were enrolled between January 2006
and February 2011, and details of study enrollment and in-
formed consent have been described previously [16-18].
Briefly, enrolled patients were admitted to the medical, sur-
gical, trauma or cardiovascular ICUs at VUMC if they
remained in the ICU the morning of day two. Exclusions
included ICU stay greater than 48 hours prior to VUMC
ICU admission, uncomplicated overdose, severe chronic
lung disease, plans to transfer out of ICU on day two and
non-mechanically ventilated or post-surgical patients in the
cardiovascular ICU.
For this analysis, we included patients who met the Berlin
definition of ARDS [7]. Patients were classified according to
Berlin level of severity as mild (PaO2/FiO2 200 to ≤
300 mmHg with PEEP ≥ 5 cm H2O or continuous positive
airway pressure (CPAP) ≥ 5 cm H2O), moderate (PaO2/
FiO2 100 to ≤ 200 mmHg with PEEP ≥ 5 cm H2O), and se-
vere (PaO2/FiO2 ≤ 100 mmHg with PEEP ≥ 5 cm H2O).
The diagnosis of ARDS could be established at any time
during the first four days in the ICU. For diagnosis, the ra-
tio of pulse oximetric saturation to fraction of inspired oxy-
gen (SpO2/FiO2) was used as a validated surrogate for
PaO2/FiO2 among patients without an arterial blood gas
measurement at the time of ARDS diagnosis: SpO2/FiO2 =
64 + 0.84 × (PaO2/FiO2) [19]. Among 2,325 patients en-
rolled in VALID, we included 550 patients who met Berlin
definition criteria for ARDS (Flow diagram Figure 1).
The Institutional Review Board (IRB) at Vanderbilt Uni-
versity (IRB#051065) approved the study.
Informed consent
Informed consent was obtained from patients or their sur-
rogates whenever possible. For patients who were unable to
provide informed consent due to their clinical condition
and for whom no surrogates were available, a waiver of in-
formed consent was granted by the IRB due to the minimal
risk of the observational study.
Lung Injury Score
The Lung Injury Score and each of its components [8] and
Berlin severity levels were calculated from the most severe
measures on the day of ARDS diagnosis or on the initial
enrollment day in VALID, whichever came last. For LIS,
each of the four components is categorized from 0 to 4,
where a higher number is worse (Table 1). The total LIS is
obtained by dividing the aggregate sum by the number of
components used. For example, if one component is un-
available then the LIS would be the sum of the three other
components divided by three.
Outcomes
The primary outcome was in-hospital mortality, defined
as death during the incident hospitalization. Secondary
Figure 1 Flow diagram of the patients included in the current study.
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fined as the number of days alive and free of mechanical
ventilation to day 28, with VFD= 0 for patients who died in
the first four weeks, [20] and among survivors to hospital
discharge: days of mechanical ventilation; days in ICU; and
length of hospital stay.Other prognostic indices
We compared LIS and Berlin level of severity to two well-
validated, general severity of illness scores: (1) Acute Physi-
ology and Chronic Health Evaluation (APACHE) II, [21]
and (2) Simplified Acute Physiology Score (SAPS) II [22].
Both scores were calculated on the day of enrollment into
VALID on the morning of ICU day two.Definitions of ARDS risk factors
Sepsis was defined according to consensus definition
[23] as evidence of infection and at least two criteria of
systemic inflammatory response syndrome. Trauma was
defined as major blunt or penetrating traumatic injury
necessitating admission to the trauma ICU. To diagnose
pneumonia, two or more of the following criteria were
required: (1) new infiltrate on chest radiograph; (2)
temperature higher than 38°C or lower than 36°C or
white blood counts more than 12,000/μl, less than
4,000/μl or band forms more than 10%; (3) positive mi-
crobiologic culture. Aspiration was defined as witnessed
or suspected aspiration events or retrieval of gastric con-
tents from the airway or endotracheal tube.Statistical analysis
For all analyses, the LIS score was treated as a continu-
ous variable and LIS components as ordinal variables.
Berlin severity levels were treated as ordinal variables.
To determine differences in LIS score according to in-
hospital mortality, we used the Student’s t-test. For LIS
components and Berlin severity levels, P-values were
generated using the Wilcoxon-rank sum test. The asso-
ciation between LIS and secondary outcomes was tested
using the Spearman correlation test. We compared the
discrimination of LIS and Berlin severity to the general
severity scores using Receiver Operating Characteristic
(ROC) curves and used the test of equality of ROC areas
to determine differences across severity indices. Calibra-
tion of the model to evaluate the concordance of ob-
served and predicted mortality was evaluated with
Hosmer-Lemeshow goodness-of-fit test, and mortality
was categorized according to four different LIS categor-
ies (0 to 1.0; 1.1 to 2.0; 2.1 to 3.0; > 3.0) to identify
whether there was trend between increasing mortality
with each increased point in the LIS score.
As a sensitivity analysis, we tested the prognostic value
of LIS in two ‘severe ARDS’ subgroups as defined as (1)
LIS ≥ 3, a cut-point used to identify ‘refractory ARDS’ for
consideration of possible rescue therapies; [11-13] and
(2) PEEP values ≥ 10 cm H2O, a cutoff which has been
associated with improved consistency in measurement
of hypoxemia [24].
Analyses were performed using STATA version 12.1
(STATA Corp, College Station, TX, USA). Statistical
Table 1 Components of the murray lung injury score [8]
Value
1. Chest radiograph score
No alveolar consolidation 0
Alveolar consolidation confined to 1
quadrant
1
Alveolar consolidation confined to 2
quadrants
2
Alveolar consolidation confined to 3
quadrants
3
Alveolar consolidation in all 4 quadrants 4
2. Hypoxemia score a
PaO2/FIO2 ≥ 300 0
PaO2/FIO2 225 to 299 1
PaO2/FIO2 175 to 224 2
PaO2/FIO2 100 to 174 3
PaO2/FIO2 < 100 4
3. PEEP score (when ventilated)
PEEP ≤ 5 cm H2O 0
PEEP 6 to 8 cm H2O 1
PEEP 9 to 11 cm H2O 2
PEEP 12 to 14 cm H2O 3
PEEP ≥ 15 cm H2O 4
4. Respiratory system compliance score
(when available)
Compliance ≥ 80 ml/cm H2O 0
Compliance 60 to 79 ml/cm
H2O
1
Compliance 40 to 59 ml/cm
H2O
2
Compliance 20 to 39 ml/cm
H2O
3
Compliance ≤ 19 ml/cm H2O 4
The final value is obtained by dividing the aggregate sum by the number
of components.
Abbreviations: PaO2/FIO2 = arterial oxygen tension to inspired oxygen
concentration ratio, PEEP = positive end-expiratory pressure.
aSpO2/FiO2 equivalent [19] used where qualifying PaO2/FIO2 not available.
Table adapted from Murray et al. Am Rev Respir Disease 138:720–723, erratum
1989:139:1065 [8].
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Results
Table 2 shows baseline characteristics among 550 pa-
tients with ARDS included in this study. The sample was
59% male and 85% white. Trauma, sepsis, and pneumo-
nia were the top ARDS risk factors, and mean LIS dif-
fered significantly across ARDS risk factor groups,
driven by a higher mean LIS score among patients with
pneumonia (P < 0.0001) (Figure 2). Patients who died in
the hospital were older, more likely to be white (whichwas accounted for by racial differences in ARDS risk fac-
tor), had increased severity of illness on presentation,
and were more likely to have sepsis and less likely to
have trauma as a risk factor for ARDS (Table 2).
LIS and clinical outcomes
The mean LIS was 2.7 ± 0.6 in hospital survivors (N =
415) compared to 2.9 ± 0.6 in non-survivors (N = 135)
(Table 3). This 0.2 point difference (95% CI 0.1 to 0.3)
was statistically significant P = 0.006. The association be-
tween LIS and in-hospital death was not modified by the
ARDS risk factor (P = 0.19 for heterogeneity) or the
presence of sepsis in the first four days after enrollment
(P = 0.68). The LIS components most strongly associated
with overall mortality were the PaO2/FiO2 (P < 0.001)
and the level of PEEP (P = 0.02). The chest radiograph
and compliance scores did not differ according to mor-
tality (Table 3). A one-point increase in LIS was associ-
ated with a 58% increased odds of in-hospital death (OR
1.58, 95% CI 1.14 to 2.19, P = 0.006).
Among secondary outcomes evaluated, VFDs were in-
versely associated with LIS (Spearman’s rho = −0.17,
P = 0.0001) with a 7% reduction in VFD (95% CI 2 to 13%,
P-value = 0.01) for every one-point increase in LIS. Among
415 hospital survivors, the LIS was positively associated
with days of mechanical ventilation (Spearman’s rho = 0.17,
P = 0.0004) and days in the ICU (Spearman’s rho = 0.13,
P = 0.007). For every one-point increase in LIS, there was a
25% increase (95% CI 9 to 43%, P = 0.001) in number of
days of mechanical ventilation and a 16% increase (95% CI
2 to 31%, P = 0.02) in number of ICU days. The LIS did not
predict total days of hospitalization (Spearman’s rho = 0.07,
P = 0.15) among hospital survivors.
LIS and Berlin definition
LIS was highly correlated with the Berlin oxygenation cri-
teria (Spearman’s rho of 0.72, P < 0.0001). LIS increased
with each increased level of Berlin severity (Figure 3 and
Table 4). Among patients characterized by the Berlin defin-
ition as mild, the mean LIS was 2.1 ± 0.4 compared to a
mean LIS of 2.5 ± 0.5 in moderate and 3.3 ± 0.4 in severe
Berlin definition ARDS (P < 0.001 for trend).
An increased Berlin level of ARDS severity was associated
with worse clinical outcomes in ARDS including increased
in-hospital mortality, decreased ventilator-free days, and in-
creased duration of mechanical ventilation in survivors
(Table 4).
Comparison of LIS and Berlin severity to general severity
scores
The area under the ROC curve (AUC) of LIS for hos-
pital mortality was 0.58 (95% CI 0.53 to 0.64) com-
pared to an AUC of 0.60 (95% CI 0.55 to 0.65) for
the Berlin severity scores. There was no statistically
Table 2 Baseline characteristics among 550 patients with acute respiratory distress syndrome (ARDS)
Characteristic Total cohort= 550 (%)
Survived to discharge Died in the hospital
P-value
(N = 415) (N = 135)
Age, mean ± SD 51 ± 18 49 ± 18 56 ± 17 < 0.001
Male 322 (59%) 247 (60%) 75 (56%) 0.42
White race 469 (85%) 432 (82%) 127 (94%) 0.01
Primary ARDS risk factora < 0.001
Sepsis 152 (27%) 104 (25%) 48 (36%)
Pneumonia 98 (18%) 69 (17%) 29 (21%)
Trauma 189 (34%) 165 (40%) 24 (18%)
Aspiration 73 (13%) 52 (13%) 21 (16%)
Otherb 38 (7%) 25 (6%) 13 (10%)
Non-invasive ventilation only on day of ARDS diagnosis 4 (1%) 1 (0%) 3 (2%) 0.02
Sepsis within first 72 hours of enrollment 357 (66%) 265 (64%) 97 (72%) 0.09
PaO2/FiO2 on the day of ARDS diagnosis, mean ± SD
c 157 ± 81 161 ± 82 145 ± 77 0.07
SpO2/FiO2 on the day of ARDS diagnosis, mean ± SD
d 169 ± 62 175 ± 59 151 ± 66 < 0.001
PEEP, mean ± SD 10 ± 4 10 ± 4 11 ± 4 0.003
Static compliance of the respiratory system, mean ± SDe 34 ± 28 34 ± 27 34 ± 30 0.95
APACHE II, mean ± SD 29 ± 8 28 ± 7 32 ± 7 < 0.001
SAPS II, mean ± SD 57 ± 16 55 ± 15 63 ± 16 < 0.001
Abbreviations: APACHE Acute Physiology and Chronic Health Evaluation, ARDS acute respiratory distress syndrome, IQR interquartile range, PaO2/FiO2, partial
pressure of arterial oxygen to the fraction of inspired oxygen, PEEP positive end-expiratory pressure, SAPS Simplified Acute Physiology Score, SD
standard deviation.
Presented as N (%) unless otherwise specified.
aPercentages not adding to 100 are due to rounding.
bIncludes pancreatitis, near drowning, transfusion-related, and so on.
c PaO2/FiO2 among 469 patients.
dSpO2/FiO2 among 512 patients.
eAmong 515 patients.
Figure 2 Box plot comparison of Lung Injury Score according
to acute respiratory distress syndrome (ARDS) risk factor in 550
patients with Berlin-defined ARDS. The line in the middle of the
box represents the median and the lines that form the box
correspond to the 25th and 75th percentiles. The LIS differs
significantly across ARDS risk factor group, which is driven by an
increased LIS among patients with pneumonia, P < 0.0001.
Compared to all other causes of ARDS, mean baseline LIS for
patients with pneumonia as a primary cause of ARDS is 0.5 points
higher (95% CI 0.3 to 0.6).
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0.47. Compared to the LIS, the AUC for APACHE II
0.66 (0.61 to 0.71) was significantly higher (P = 0.04);
the AUC for SAPS II was also higher (0.63, 95% CI
0.58 to 0.69) but this difference was not statistically
significant (P = 0.22) (Figure 4). Calibration was ad-
equate for LIS, Berlin severity and both severity of ill-
ness scores, with similar expected to observed
mortality across subgroups (data not shown). All
scores passed the Hosmer-Lemeshow goodness-of-fit
test with P-values > 0.25. Figure 5 demonstrates that
mortality increased for each one-point increase in
LIS.
Sensitivity analyses
Using a cut-point of a LIS score of ≥ 3, high LIS was
present in 45% (N = 249) of patients on the day of ARDS
diagnosis, with 30% mortality in the high LIS group
compared with 20% mortality in the lower LIS group
(P = 0.006). The AUC at this cut-point was 0.57 (95% CI
0.52 to 0.62). Discrimination of LIS was not improved in
342 (62%) patients with PEEP values ≥ 10 cm H2O (AUC
0.58, 95% CI 0.51 to 0.65).
Table 3 Lung Injury Score (LIS) and component scores
according to in-hospital mortality in 550 patients on day
of acute respiratory distress syndrome (ARDS) diagnosisa
Overall Died N = 135 Lived N = 415 P-value
LIS score, mean ± SD 2.9 ± 0.6 2.7 ± 0.6 0.006b
Chest radiograph score 4 (3 to 4) 4 (3 to 4) 0.77
PaO2/FiO2 category 4 (3 to 4) 3 (2 to 4) < 0.001
PEEP category 2 (1 to 3) 2 (0 to 3) 0.02
Compliance category 3 (3 to 3) 3 (3 to 3) 0.48
aPresented as median (interquartile range) and P-value presented as Wilcoxon-
rank sum unless otherwise specified. P-values are similar using the
Student’s t-test.
bP-value generated using the Student’s t-test. P = 0.004 using Wilcoxon-rank
sum statistic.
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Although the four-point LIS was never intended as a
prognostic tool, it has been used as a measure of the se-
verity of lung injury that thereby infers prognostic value.
The recently developed Berlin definition of ARDS in-
cludes a measure of lung injury severity based on three
levels of hypoxemia and baseline PEEP of at least 5 cm
H2O [7]. Our study tested the predictive validity of LIS
on mortality and morbidity in a large, heterogeneous
group of patients with Berlin definition ARDS. We
found that although LIS at the time of ARDS diagnosis
was associated with in-hospital mortality, the difference
between mean LIS in those who died and lived was only
0.2 points, a difference of minimal clinical significance.
Of the four LIS components, only PaO2/FiO2 and PEEP
categories were associated with mortality overall. The
discrimination of LIS for in-hospital mortality was com-
parable to the Berlin severity scale and only marginally
better than chance alone. The predictive validity was not
improved when evaluated in more severe subgroupsFigure 3 Box plot comparison of Lung Injury Score according
to Berlin definition severity in 550 patients with Berlin
definition acute respiratory distress syndrome (ARDS). The line
in the middle of the box represents the median and the lines that
form the box correspond to the 25th and 75th percentiles. The LIS
increases with increase Berlin definition severity, P < 0.001 for trend.such as those with higher PEEP or LIS ≥ 3. We also
found that LIS was predictive of the duration of mech-
anical ventilation and days in the ICU. This finding was
important, as LIS may be more suited to discriminate
pulmonary-specific outcomes. The Berlin definition se-
verity stages were associated with mortality and also
found to be associated with increased mechanical venti-
lation requirements. The predictive validity of Berlin cri-
teria was similarly marginal and failed to identify three
distinct mortality classes with a mortality of 18% in mild
versus 19% in moderate ARDS.
Overall, our findings are consistent with the findings
presented in the development of the Berlin definition for
ARDS [7]. Although several components included in the
LIS were considered for the Berlin definition, including
severity of radiographic criteria, higher levels of PEEP,
and static respiratory compliance, they were ultimately
dropped in the final Berlin definition for lack of additive
predictive value. Similarly, we found that only PEEP cat-
egory and level of hypoxemia in the LIS were associated
with mortality. We also found that both LIS and the
Berlin definition were associated with the duration of
mechanical ventilation. Only LIS was significantly asso-
ciated with duration of ICU stay among survivors,
though this correlation was weak and there was a simi-
lar, non-statistical trend for the Berlin severity stages.
Clinical measures of severity of lung injury have limi-
tations. First, measures of lung injury will not perform
well as prognostic measures because non-pulmonary fac-
tors including age, severity of sepsis, co-morbidities and
non-pulmonary organ failure remain the most influential
predictors of hospital mortality in ARDS, [25-39] and
non-resolving respiratory failure accounts for less than
20% of ARDS deaths [34-36]. Also, although the finding
that PaO2/FiO2 level is associated with mortality is con-
sistent with the findings reported from cohorts used for
empirical analysis in the development of the Berlin
ARDS definition, [40-46] this has not been demonstrated
consistently, a finding that may be attributable, in part,
to practice variability in mechanical ventilation settings,
which is known to have a large effect on PaO2/FiO2
levels [5,6,24,47,48]. Furthermore, post-mortem studies
highlight the poor accuracy that clinical definitions such
as the Berlin criteria have for histological definitions of
diffuse alveolar damage, which are found in only a mi-
nority of patients with clinical ARDS [49,50]. Nonethe-
less, clinical measures of lung injury severity remain
necessary to identify patients for ARDS treatments and
clinical trials.
To our knowledge, our study is the first to report a
statistically significant association between LIS and mor-
tality in ARDS [5,24,26,28,31,41,51]. Prior studies were
limited by small sample size (largest N = 259), mostly
considered only a subset of patients with ARDS (PaO2/
Table 4 Predictive validity of Berlin definition acute respiratory distress syndrome (ARDS) patients in Validation of
biomarkers in Acute Lung Injury Diagnosis (VALID)
Mild Moderate Severe P-valuea
Overall number (%) of patients, N = 550 76 (14) 257 (47) 217 (39)
Lung Injury Score, mean ± SD 2.1 ± 0.4 2.5 ± 0.5 3.3 ± 0.4 < 0.001
Mortality, number (%) 14 (18) 48 (19) 73 (34) < 0.001
Ventilator-free days, median (IQR) 20 (7.5 to 25) 18 (9 to 23) 14 (0 to 22) < 0.001
Number (%) of survivors, N = 415 62 (15) 209 (50) 144 (35)
Duration of mechanical ventilation in survivors, median (IQR) 6 (3 to 12) 7 (4 to 13) 8 (5 to 14.5) 0.006
ICU days in survivors, median (IQR) 9 (6 to 15) 10 (6 to 16) 11.5 (7 to 19) 0.07
Length of hospitalization in survivors, median (IQR) 16 (10 to 23) 16 (11 to 26) 19 (13 to 29) 0.08
aTest of trend.
Abbreviations: ARDS = acute respiratory distress syndrome, ICU = intensive care unit, IQR = interquartile range, SD = standard deviation.
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ducted prior to recent treatment advancements includ-
ing low tidal volume ventilation. At least two studies
demonstrated a similarly increased LIS in non-survivors
of ARDS compared to survivors as observed in the
current study (approximately 0.2 points), but did not
have the power to detect a statistically significant differ-
ence [5,41]. Furthermore, a study by Villar et al. identi-
fied LIS as an independent predictor of developing
established AECC-defined ARDS after one day of stan-
dardized ventilator management [24], which is consist-
ent with our finding that LIS predicts pulmonary
outcomes. The lack of a significant association between
LIS and clinical outcomes in these smaller studies un-
derscores our finding that LIS may be a marginal though
not clinically relevant predictor of outcomes. Finally, it
is also possible that we detected an association between
LIS and clinical outcomes as a result of limiting our
sample to patients meeting the Berlin definition ofFigure 4 Comparison of Receiver Operating Characteristic
Curves of Lung Injury Score (LIS) to Berlin severity, APACHE II
and SAPS II. Discrimination of LIS for mortality is similar to Berlin
severity (P = 0.47) and SAPS II (P = 0.22) and inferior to APACHE
II (P = 0.04).ARDS, a definition that was created to improve the val-
idity and reliability of the ARDS diagnosis [7].
It is important to note that the mortality rate in our study
was lower than in several other epidemiological studies on
ARDS [7,52-55]. This was in part due to the high propor-
tion of patients with trauma-related ARDS, for whom the
in-hospital mortality rate was 13%. Also, our outcome was
in-hospital mortality rather than 60- or 90-day mortality in
some other studies. However, even with a lower overall
mortality, we detected a statistically significant association
between both LIS and Berlin severity and both in-hospital
death and more prolonged respiratory failure, demonstrat-
ing sufficient power. We recently demonstrated that death
after discharge from ARDS hospitalization is more related
to underlying co-morbid illness and age rather than severity
of ARDS and determined that in-hospital mortality would
be more sensitive to measures of lung injury severity [56].
Furthermore, using an endpoint of mortality at 90 days did
not change our results (data not shown) although overall
mortality increased by 10%.Figure 5 Categories of Lung Injury Score (LIS) by in-hospital
mortality in 550 patients with acute respiratory distress
syndrome (ARDS). No patients with LIS between 0 and 1.
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and outcomes, these results should be considered in view
of the current use of LIS for clinical and research applica-
tions in the context of a the new Berlin definition for
ARDS. A single LIS measurement on initial diagnosis of
ARDS did not provide additive prognostic information over
the three severity categories of the Berlin definition alone.
In addition, with only marginal discrimination for mortality,
our results do not clearly support the use of LIS cut-points
used to define refractory ARDS for consideration of experi-
mental approaches such as extracorporeal membrane oxy-
genation [13].
Several limitations of the study deserve mention. First, it
was performed at a single, tertiary care site; therefore, gen-
eralizing the results to other settings may be limited. How-
ever, using a large, multi-ICU sample, including a broad
range of patients with ARDS, is likely to improve
generalizability overall. Furthermore, our test of the prog-
nostic value of the Berlin definition severity stages repli-
cated those described in the initial Berlin definition, further
suggesting our sample is representative of a broader ARDS
population. Second, we did not evaluate the prognostic
value of change in LIS over time. Further studies will be re-
quired to determine whether measurement of change in
LIS is a more useful prognostic indicator as has been previ-
ously suggested [57]. Third, our primary outcome was all-
cause in-hospital mortality, so we were not able to directly
assess the prognostic value of LIS in identifying the minor-
ity of patients with ARDS who die of respiratory failure.
However, secondary outcomes of VFD and days of mechan-
ical ventilation were assessed as measures of pulmonary-
specific outcomes. Lastly, our general severity scores were
generated over the first 24 hours of enrollment, whereas
LIS was calculated on the day of ARDS diagnosis. This was
the same day for the vast majority (N = 419, 76%) of the
study cohort. However, the time difference for the 24%
should provide an advantage for LIS as a prognostic
marker. Therefore, improved test characteristics in the gen-
eral severity scores compared to LIS may have been an
underestimate of this difference.
Conclusions
In conclusion, the LIS remains a widely utilized measure of
initial lung injury severity in ARDS but does not provide
additional prognostic value for mortality or duration of
mechanical ventilation compared to the Berlin definition of
ARDS. White the four-point LIS may still have value for re-
search purposes to more completely define abnormal lung
physiology, it has limited value for estimating prognosis in
ARDS patients.
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VFD: ventilator-free days; VUMC: Vanderbilt University Medical Center.
Competing interests
No author (KNK, AM, HZ, MAM, LBW) reports a conflict of interest. Dr. Calfee
has served on medical advisory boards for Cerus Corp and Glaxo Smith Kline.
Authors’ contributions
KNK, CSC, MAM and LBW contributed to study design, data analysis and
interpretation and drafting and revising the manuscript critically for
important intellectual content. HZ and AKM contributed to acquisition of
data, and analysis and interpretation of data and revising the manuscript. All
authors approved the manuscript to be published, and KNK is the guarantor
of the entire manuscript.
Funding sources
At the time the research was conducted Dr. Kangelaris was supported by the
Society of Hospital Medicine Young Researchers Award, the NIH National
Center for Advancing Translational Sciences through UCSF-CTSI KL2
TR000143, and NHLBI 1K23HL116800-01. Dr. Calfee was supported by NHLBI
HL090833 and HL110989. Dr Ware was supported by NHLBI HL081332, and
HL103836. This work was supported by the National Institutes of Health. Dr.
Matthay was supported by NHLBI HL51856.
We thank the patients and the family members of those who participated in
the VALID study.
Author details
1Department of Medicine, Division of Hospital Medicine, University of
California, San Francisco 94143-0131, CA, USA. 2Department of Medicine,
Division of Pulmonary and Critical Care, University of California, San
Francisco, CA, USA. 3Department of Anesthesia and Perioperative Care,
University of California, San Francisco, CA, USA. 4Department of Surgery,
Vanderbilt University School of Medicine, Nashville, TN, USA. 5Department of
Medicine, Division of Allergy, Pulmonary and Critical Care Medicine,
Vanderbilt University School of Medicine, Nashville, TN, USA.
Received: 19 September 2013 Accepted: 1 February 2014
Published: 18 February 2014
References
1. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD: Recent trends in
acute lung injury mortality: 1996 to 2005. Crit Care Med 2009,
37(5):1574–1579.
2. Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, Jimenez E,
Mohan A, Khan RA, Whittle J, et al: Nationwide trends of severe sepsis in
the 21st century (2000 to 2007). Chest 2011, 140(5):1223–1231.
3. Altman DG: Statistics and ethics in medical research: III how large a
sample? Br Med J 1980, 281(6251):1336–1338.
4. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche
PC, Lang T: The revised CONSORT statement for reporting randomized
trials: explanation and elaboration. Ann Intern Med 2001, 134(8):663–694.
5. Villar J, Perez-Mendez L, Basaldua S, Blanco J, Aguilar G, Toral D, Zavala E,
Romera MA, Gonzalez-Diaz G, Nogal FD, et al: A risk tertiles model for
predicting mortality in patients with acute respiratory distress syndrome:
age, plateau pressure, and P(aO(2))/F(IO(2)) at ARDS onset can predict
mortality. Respir Care 2011, 56(4):420–428.
6. Villar J, Perez-Mendez L, Blanco J, Anon JM, Blanch L, Belda J, Santos-Bouza
A, Fernandez RL, Kacmarek RM, Spanish Initiative for Epidemiology S, et al: A
universal definition of ARDS: the PaO2/FiO2 ratio under a standard
ventilatory setting – a prospective, multicenter validation study.
Intensive Care Med 2013, 39(4):583–592.
7. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E,
Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin
definition. JAMA 2012, 307(23):2526–2533.
Kangelaris et al. Annals of Intensive Care 2014, 4:4 Page 9 of 10
http://www.annalsofintensivecare.com/content/4/1/48. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the
adult respiratory distress syndrome. Am Rev Respir Dis 1988,
138(3):720–723.
9. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR,
Morris A, Spragg R: The American-European Consensus Conference on ARDS.
Definitions, mechanisms, relevant outcomes, and clinical trial coordination.
Am J Respir Crit Care Med 1994, 149(3 Pt 1):818–824.
10. Troche G, Moine P: Is the duration of mechanical ventilation predictable?
Chest 1997, 112(3):745–751.
11. Diaz JV, Brower R, Calfee CS, Matthay MA: Therapeutic strategies for severe
acute lung injury. Crit Care Med 2010, 38(8):1644–1650.
12. Meduri GU, Chinn AJ, Leeper KV, Wunderink RG, Tolley E, Winer-Muram HT, Khare
V, Eltorky M: Corticosteroid rescue treatment of progressive fibroproliferation
in late ARDS. Patterns of response and predictors of outcome. Chest 1994,
105(5):1516–1527.
13. Peek GJ, Clemens F, Elbourne D, Firmin R, Hardy P, Hibbert C, Killer H,
Mugford M, Thalanany M, Tiruvoipati R, et al: CESAR: conventional
ventilatory support versus extracorporeal membrane oxygenation for
severe adult respiratory failure. BMC Health Serv Res 2006, 6:163.
14. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M,
Umberger R: Methylprednisolone infusion in early severe ARDS: results of
a randomized controlled trial. Chest 2007, 131(4):954–963.
15. Murray JF, Matthay MA, Luce JM, Flick MR: Web of science citation report
of articles citing: an expanded definition of the adult respiratory distress
syndrome. Am Rev Respir Dis 1988, 138(3):720–723 [http://apps.
webofknowledge.com/summary.do?SID=2F4E2Odl57KCeSSIpo4&
product=WOS&qid=1&search_mode=GeneralSearch]
16. Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KG, Wickersham N,
Bossert F, Ikizler TA: Urine neutrophil gelatinase-associated lipocalin mod-
erately predicts acute kidney injury in critically ill adults. J Am Soc
Nephrol 2009, 20(8):1823–1832.
17. Janz DR, Bastarache JA, Peterson JF, Sills G, Wickersham N, May AK, Roberts LJ
2nd, Ware LB: Association between cell-free hemoglobin, acetaminophen, and
mortality in patients with sepsis: an observational study. Crit Care Med 2013,
41(3):784–790.
18. O’Neal HR Jr, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, May AK,
Bernard GR, Ware LB: Prehospital statin and aspirin use and the
prevalence of severe sepsis and acute lung injury/acute respiratory
distress syndrome. Crit Care Med 2011, 39(6):1343–1350.
19. Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB:
Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients
with acute lung injury or ARDS. Chest 2007, 132(2):410–417.
20. Schoenfeld DA, Bernard GR: Statistical evaluation of ventilator-free days as an
efficacy measure in clinical trials of treatments for acute respiratory distress
syndrome. Crit Care Med 2002, 30(8):1772–1777.
21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of
disease classification system. Crit Care Med 1985, 13(10):818–829.
22. Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology
score (SAPS II) based on a European/North American multicenter study.
JAMA 1993, 270(24):2957–2963.
23. American college of chest physicians/society of critical care medicine
consensus conference: Definitions for sepsis and organ failure and
guidelines for the use of innovative therapies in sepsis. Crit Care Med
1992, 20:864-874.
24. Villar J, Perez-Mendez L, Lopez J, Belda J, Blanco J, Saralegui I, Suarez-
Sipmann F, Lubillo S, Kacmarek RM: An early PEEP/FIO2 trial identifies
different degrees of lung injury in patients with acute respiratory
distress syndrome. Am J Respir Crit Care Med 2007, 176(8):795–804.
25. Bone RC, Maunder R, Slotman G, Silverman H, Hyers TM, Kerstein MD,
Ursprung JJ: An early test of survival in patients with the adult
respiratory distress syndrome. The PaO2/FIo2 ratio and its differential
response to conventional therapy. Prostaglandin E1 Study Group.
Chest 1989, 96(4):849–851.
26. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA: Identification
of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care
Med 1995, 152(6 Pt 1):1818–1824.
27. Ely EW, Wheeler AP, Thompson BT, Ancukiewicz M, Steinberg KP, Bernard GR:
Recovery rate and prognosis in older persons who develop acute lung injury
and the acute respiratory distress syndrome. Ann Intern Med 2002,
136(1):25–36.28. Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, Dhainaut JF,
Brunet F: Early predictive factors of survival in the acute respiratory distress
syndrome. A multivariate analysis. Am J Respir Crit Care Med 1998,
158(4):1076–1081.
29. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay MA:
Pulmonary dead-space fraction as a risk factor for death in the acute
respiratory distress syndrome. N Engl J Med 2002, 346(17):1281–1286.
30. Seeley E, McAuley DF, Eisner M, Miletin M, Matthay MA, Kallet RH:
Predictors of mortality in acute lung injury during the era of lung
protective ventilation. Thorax 2008, 63(11):994–998.
31. Zilberberg MD, Epstein SK: Acute lung injury in the medical ICU:
comorbid conditions, age, etiology, and hospital outcome. Am J Respir
Crit Care Med 1998, 157(4 Pt 1):1159–1164.
32. Cooke CR, Shah CV, Gallop R, Bellamy S, Ancukiewicz M, Eisner MD, Lanken PN,
Localio AR, Christie JD: A simple clinical predictive index for objective
estimates of mortality in acute lung injury. Crit Care Med 2009, 37(6):1913–1920.
33. Cooke CR, Kahn JM, Caldwell E, Okamoto VN, Heckbert SR, Hudson LD,
Rubenfeld GD: Predictors of hospital mortality in a population-based cohort of
patients with acute lung injury. Crit Care Med 2008, 36(5):1412–1420.
34. Estenssoro E, Dubin A, Laffaire E, Canales H, Saenz G, Moseinco M, Pozo M,
Gomez A, Baredes N, Jannello G, et al: Incidence, clinical course, and
outcome in 217 patients with acute respiratory distress syndrome.
Crit Care Med 2002, 30(11):2450–2456.
35. Montgomery AB, Stager MA, Carrico CJ, Hudson LD: Causes of mortality in
patients with the adult respiratory distress syndrome. Am Rev Respir Dis
1985, 132(3):485–489.
36. Stapleton RD, Wang BM, Hudson LD, Rubenfeld GD, Caldwell ES, Steinberg KP:
Causes and timing of death in patients with ARDS. Chest 2005, 128(2):525–532.
37. Brown LM, Calfee CS, Matthay MA, Brower RG, Thompson BT, Checkley W: A
simple classification model for hospital mortality in patients with acute lung
injury managed with lung protective ventilation. Crit Care Med 2011,
39(12):2645–2651.
38. Bull TM, Clark B, McFann K, Moss M, National Institutes of Health/National
Heart L, Blood Institute AN: Pulmonary vascular dysfunction is associated
with poor outcomes in patients with acute lung injury. Am J Respir Crit
Care Med 2010, 182(9):1123–1128.
39. Cepkova M, Kapur V, Ren X, Quinn T, Zhuo H, Foster E, Liu KD, Matthay MA:
Pulmonary dead space fraction and pulmonary artery systolic pressure
as early predictors of clinical outcome in acute lung injury. Chest 2007,
132(3):836–842.
40. Bellani G, Guerra L, Musch G, Zanella A, Patroniti N, Mauri T, Messa C, Pesenti A:
Lung regional metabolic activity and gas volume changes induced by tidal
ventilation in patients with acute lung injury. Am J Respir Crit Care Med 2011,
183(9):1193–1199.
41. Bersten AD, Edibam C, Hunt T, Moran J: Incidence and mortality of acute
lung injury and the acute respiratory distress syndrome in three
Australian States. Am J Respir Crit Care Med 2002, 165(4):443–448.
42. Britos M, Smoot E, Liu KD, Thompson BT, Checkley W, Brower RG, National
Institutes of Health Acute Respiratory Distress Syndrome Network I: The value of
positive end-expiratory pressure and Fio(2) criteria in the definition of the
acute respiratory distress syndrome. Crit Care Med 2011, 39(9):2025–2030.
43. Needham DM, Dennison CR, Dowdy DW, Mendez-Tellez PA, Ciesla N, Desai
SV, Sevransky J, Shanholtz C, Scharfstein D, Herridge MS, et al: Study
protocol: the Improving Care of Acute lung injury Patients (ICAP) study.
Crit Care 2006, 10(1):R9.
44. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ,
Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med
2005, 353(16):1685–1693.
45. Terragni PP, Del Sorbo L, Mascia L, Urbino R, Martin EL, Birocco A, Faggiano C,
Quintel M, Gattinoni L, Ranieri VM: Tidal volume lower than 6 ml/kg enhances
lung protection: role of extracorporeal carbon dioxide removal.
Anesthesiology 2009, 111(4):826–835.
46. Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, Gandini G,
Herrmann P, Mascia L, Quintel M, et al: Tidal hyperinflation during low tidal
volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care
Med 2007, 175(2):160–166.
47. Ferguson ND, Kacmarek RM, Chiche JD, Singh JM, Hallett DC, Mehta S, Stewart
TE: Screening of ARDS patients using standardized ventilator settings:
influence on enrollment in a clinical trial. Intensive Care Med 2004,
30(6):1111–1116.
Kangelaris et al. Annals of Intensive Care 2014, 4:4 Page 10 of 10
http://www.annalsofintensivecare.com/content/4/1/448. Villar J, Perez-Mendez L, Kacmarek RM: Current definitions of acute lung
injury and the acute respiratory distress syndrome do not reflect their
true severity and outcome. Intensive Care Med 1999, 25(9):930–935.
49. Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA,
Penuelas O, Cortes-Puch I, Cardinal-Fernandez P, Lorente JA, Frutos-Vivar F:
Comparison of the Berlin definition for acute respiratory distress
syndrome with autopsy. Am J Respir Crit Care Med 2013, 187(7):761–767.
50. Thompson BT, Matthay MA: The Berlin definition of ARDS versus
pathological evidence of diffuse alveolar damage. Am J Respir Crit Care
Med 2013, 187(7):675–677.
51. Heffner JE, Brown LK, Barbieri CA, Harpel KS, DeLeo J: Prospective
validation of an acute respiratory distress syndrome predictive score.
Am J Respir Crit Care Med 1995, 152(5 Pt 1):1518–1526.
52. Cox proportional hazards sample size calculation. [http://cct.jhsph.edu/
javamarc/index.htm]
53. Li G, Malinchoc M, Cartin-Ceba R, Venkata CV, Kor DJ, Peters SG, Hubmayr RD,
Gajic O: Eight-year trend of acute respiratory distress syndrome: a
population-based study in Olmsted County, Minnesota. Am J Respir Crit Care
Med 2011, 183(1):59–66.
54. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC,
Stather DR, Li A, Jones A, et al: Has mortality from acute respiratory distress
syndrome decreased over time?: A systematic review. Am J Respir Crit Care
Med 2009, 179(3):220–227.
55. Villar J, Blanco J, Anon JM, Santos-Bouza A, Blanch L, Ambros A, Gandia F,
Carriedo D, Mosteiro F, Basaldua S, et al: The ALIEN study: incidence and
outcome of acute respiratory distress syndrome in the era of lung protective
ventilation. Intensive Care Med 2011, 37(12):1932–1941.
56. Wang CY, Calfee CS, Paul DW, Janz DR, May AK, Zhuo H, Bernard GR,
Matthay MA, Ware LB, Kangelaris KN: One-year mortality and predictors of
death among hospital survivors of acute respiratory distress syndrome.
Intensive Care Med 2014. http://www.ncbi.nlm.nih.gov/pubmed/24435201.
57. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc
B, Connors AF Jr, Hite RD, Harabin AL: Comparison of two fluid-management
strategies in acute lung injury. N Engl J Med 2006, 354(24):2564–2575.
doi:10.1186/2110-5820-4-4
Cite this article as: Kangelaris et al.: Is there still a role for the lung injury
score in the era of the Berlin definition ARDS?. Annals of Intensive Care
2014 4:4.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
